Merck KGaA (MKGAF)
162.95
+7.50
(+4.82%)
USD |
OTCM |
Oct 06, 16:00
Merck Gross Profit Margin (Quarterly) : 58.26% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.26% |
| March 31, 2026 | 59.70% |
| December 31, 2025 | 56.41% |
| September 30, 2025 | 60.42% |
| June 30, 2025 | 57.60% |
| March 31, 2025 | 59.56% |
| December 31, 2024 | 57.20% |
| September 30, 2024 | 59.70% |
| June 30, 2024 | 60.41% |
| March 31, 2024 | 58.77% |
| December 31, 2023 | 55.46% |
| September 30, 2023 | 58.21% |
| June 30, 2023 | 59.66% |
| March 31, 2023 | 62.72% |
| December 31, 2022 | 59.65% |
| September 30, 2022 | 63.02% |
| June 30, 2022 | 62.12% |
| March 31, 2022 | 61.77% |
| December 31, 2021 | 62.42% |
| September 30, 2021 | 62.62% |
| June 30, 2021 | 62.77% |
| March 31, 2021 | 62.84% |
| December 31, 2020 | 60.96% |
| September 30, 2020 | 60.06% |
| June 30, 2020 | 60.91% |
| Date | Value |
|---|---|
| March 31, 2020 | 62.15% |
| December 31, 2019 | 61.42% |
| September 30, 2019 | 63.54% |
| June 30, 2019 | 63.38% |
| March 31, 2019 | 63.05% |
| December 31, 2018 | 62.54% |
| September 30, 2018 | 64.15% |
| June 30, 2018 | 64.43% |
| March 31, 2018 | 63.86% |
| December 31, 2017 | 63.87% |
| September 30, 2017 | 64.83% |
| June 30, 2017 | 65.52% |
| March 31, 2017 | 59.70% |
| December 31, 2016 | 58.41% |
| September 30, 2016 | 59.56% |
| June 30, 2016 | 58.69% |
| March 31, 2016 | 57.30% |
| December 31, 2015 | 60.39% |
| September 30, 2015 | 63.82% |
| June 30, 2015 | 62.56% |
| March 31, 2015 | 62.12% |
| December 31, 2014 | 61.12% |
| September 30, 2014 | 61.51% |
| June 30, 2014 | 63.56% |
| March 31, 2014 | 64.52% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bayer AG | 58.24% |
| Dermapharm Holding SE | 33.36% |
| AstraZeneca PLC | 76.09% |
| GSK Plc | 75.05% |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.19% |
| Return on Assets | 4.67% |
| Return on Invested Capital | 5.87% |
| Profit Margin (Quarterly) | 9.09% |
| Operating Margin (Quarterly) | 21.51% |
| Return on Net Operating Assets | 5.42% |